Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026
Solventum Rg-WI (NY Consolidated)
Závěr k 13.2.2026 Změna (%) Změna (USD) Objem obchodů (USD)
75,55 -0,53 -0,40 59 306 733
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti
Obecné informace
Název společnostiSolventum Corp
TickerSOLV
Kmenové akcie:Ordinary Shares
RICSOLV.K
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2024 22 000
Akcie v oběhu k 31.10.2025 173 447 557
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
UliceC/O 3M Company
MěstoST. PAUL
PSČ55144-1000
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon16 517 331 110
Fax13026365454

Business Summary: Solventum Corporation is a global healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer needs. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Solventum Corp revenues increased 2% to $6.33B. Net income increased from $448M to $1.49B. Revenues reflect MedSurg segment increase of 3% to $3.58B, Corporate and Unallocated segment increase from $45M to $105M, Health Information Systems segment increase of 4% to $1.01B, United States segment increase of 52% to $3.51B, International segment increase of 58% to $2.81B.
Odvětvová klasifikace
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical Appliance and Supplies Manufacturing
NAICSDental Equipment and Supplies Manufacturing
NAICSMedical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
NAICSCustom Computer Programming Services
SICSurgical Appliances And Supplies
SICDental Equipment And Supplies
SICMedical And Hospital Equipment
SICComputer Programming Services



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, DirectorBryan Hanson5901.01.2024
Chief Financial OfficerWayde McMillan5501.01.2024
President - Health Information SystemsGarri Garrison6501.01.2024
President - Purification and FiltrationVaughn Grannis6101.01.2024
President - Dental SolutionsKarim Mansour5101.01.2024
Chief Human Resources OfficerTammy Gomez5301.01.2024
Chief Information and Digital OfficerAmy Landucci5001.01.2024
Chief Strategy & Corporate Development OfficerSanjiv Arora5901.01.2024
Chief Supply Chain OfficerPaul Harrington5601.01.2024
Chief Legal Affairs OfficerMarcela Kirberger5801.01.2024